{"abstract": "Amgen, the world\u2019s biggest biotechnology company, is seeking to buy distressed biotechnology companies at bargain prices.", "web_url": "https://dealbook.nytimes.com/2008/11/04/amgen-sees-attractive-opportunities-in-biotech/", "snippet": "", "lead_paragraph": "Amgen, the world\u2019s biggest biotechnology company, is seeking to buy distressed biotechnology companies at bargain prices.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Amgen Sees \u2018Attractive Opportunities\u2019 in Biotech", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [], "pub_date": "2008-11-04T20:33:45+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Dealbook", "person": [{"firstname": "Dealbook", "middlename": null, "lastname": "", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/1b4f6689-b17e-598b-8e23-ef92f16996b5", "word_count": 201, "uri": "nyt://article/1b4f6689-b17e-598b-8e23-ef92f16996b5"}